DEXCOM, INC. Deferred Tax Assets, Tax Deferred Expense, Other
DEXCOM, INC. (DXCM) had Deferred Tax Assets, Tax Deferred Expense, Other of $142.40 million as of 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2025-02-18
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $142.40M.
- 2023-08-31: Deferred Tax Assets, Tax Deferred Expense, Other $193.20M; Deferred Tax Assets, Tax Deferred Expense, Other as first filed $186.60M.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $49.30M.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $53.60M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other | Deferred Tax Assets, Tax Deferred Expense, Other as first filed |
|---|---|---|
| 2024-12-31 | $142.40M 10-K · filed 2025-02-18 | |
| 2023-08-31 | $193.20M 10-K · filed 2024-02-08 | $186.60M 10-Q · filed 2023-10-26 |
| 2021-12-31 | $49.30M 10-K · filed 2022-02-14 | |
| 2020-12-31 | $53.60M 10-K · filed 2022-02-14 | |
| 2019-12-31 | $57.10M 10-K · filed 2021-02-11 | |
| 2018-12-31 | $62.10M 10-K · filed 2020-02-13 | |
| 2017-12-31 | $8.40M 10-K · filed 2019-02-21 | |
| 2016-12-31 | $14.30M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $17.00M 10-K · filed 2017-02-28 | |
| 2014-12-31 | $5.00M 10-K · filed 2016-02-23 | |
| 2013-12-31 | $7.20M 10-K · filed 2015-02-25 | |
| 2012-12-31 | $8.10M 10-K · filed 2014-02-20 | |
| 2011-12-31 | $10.50M 10-K · filed 2013-02-21 | $10.53M 10-K · filed 2012-02-23 |
| 2010-12-31 | $15.74M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |